(9H-CARBAZOL-9-YL)(PHENYL)METHANONE, 95.0%, 100mg

CYCLOBUTANAMINE, 3-(3,4-DIMETHOXYPHENOXY)-, HCL (1:1), TRANS-, 95.0%, 1g

Dipropylene glycol monobutyl ether, min 98%, for synthesis, 1L, plastic packaging.

(R)-Isopropyl pyrrolidine-2-carboxylate hydrochloride, 100mg

3-Ethylquinoline, 95+%, 1g

5-Bromo-2-methoxy-3-methylpyridine, 97.0%, 1g

5-Fluorothiophene-2-carbonitrile, 95.0%, 5g

H-Ser-OH, 98.00%, 1kg

GC capillary column ROTI®Cap-1701, 30 m, 0.25 mm, 0.50 µm, 1 Piece(s)

(R)-3-Aminotetrahydrofuran hydrochloride, 97.0%, 25g

5-Oxa-2-azaspiro[3.4]octane hydrochloride, 95.0%, 5g

1-(9-Ethyl-9H-carbazol-3-yl)ethanone, 95.0%, 5g

4-iodo-5-methoxy-1H-pyrazole, 97%, 1g